Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuldeep Cheent

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Gut|September 30, 2010
Natural killer cells and hepatitis C: action and reactionKuldeep Cheent, Salim I Khakoo
Immunology|March 13, 2009
Natural killer cells: integrating diversity with functionKuldeep Cheent, Salim I Khakoo
BMJ Case Reports|May 14, 2017
Navigating the benefits and burdens of life-saving treatment in severely decompensated cirrhosis: an illustrative, multisourced narrativePhilip Berry, Kuldeep Cheent, Heather Lewis, et al.
Clinical Medicine (London, England)|April 9, 2019
Evaluating the benefits of using a scoring system to aid management of alcohol withdrawal at an NHS district general hospitalPeter Foulser, Leesa Everett, Margaret Parsons, et al.
JRSM Open|April 15, 2020
A case report of Adult-onset Still's disease presenting with acute fibrinous and organising pneumoniaRobert Perry, Dimitrios Christidis, Andrew G Nicholson, et al.
Journal of Surgical Case Reports|July 13, 2022
Obstructive jaundice, early satiety and xerostomia in an 82-year-old womanKunal Bhanot, Muhesh Taheem, Robert Perry, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's diseaseKuldeep Cheent, Jonathan Nolan, Sohail Shariq, et al.
Infectious Disease Reports|January 25, 2022
Recurrent <i>Campylobacter jejuni</i> Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case ReportBlair Merrick, Aravind Gokul Tamilarasan, Raphael Luber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Peptide antagonism as a mechanism for NK cell activationLena Fadda, Gwenoline Borhis, Parvin Ahmed, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gut|September 30, 2010
Natural killer cells and hepatitis C: action and reactionKuldeep Cheent, Salim I Khakoo
Immunology|March 13, 2009
Natural killer cells: integrating diversity with functionKuldeep Cheent, Salim I Khakoo
BMJ Case Reports|May 14, 2017
Navigating the benefits and burdens of life-saving treatment in severely decompensated cirrhosis: an illustrative, multisourced narrativePhilip Berry, Kuldeep Cheent, Heather Lewis, et al.
Clinical Medicine (London, England)|April 9, 2019
Evaluating the benefits of using a scoring system to aid management of alcohol withdrawal at an NHS district general hospitalPeter Foulser, Leesa Everett, Margaret Parsons, et al.
JRSM Open|April 15, 2020
A case report of Adult-onset Still's disease presenting with acute fibrinous and organising pneumoniaRobert Perry, Dimitrios Christidis, Andrew G Nicholson, et al.
Journal of Surgical Case Reports|July 13, 2022
Obstructive jaundice, early satiety and xerostomia in an 82-year-old womanKunal Bhanot, Muhesh Taheem, Robert Perry, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's diseaseKuldeep Cheent, Jonathan Nolan, Sohail Shariq, et al.
Infectious Disease Reports|January 25, 2022
Recurrent <i>Campylobacter jejuni</i> Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case ReportBlair Merrick, Aravind Gokul Tamilarasan, Raphael Luber, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2010
Peptide antagonism as a mechanism for NK cell activationLena Fadda, Gwenoline Borhis, Parvin Ahmed, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Pageof 1